PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of ...(g statements preceded by followed by or ...)

Date:2/8/2008

g statements preceded by, followed by, or that include the words "potential"; "believe"; "anticipate"; "intend"; "plan"; "expect"; "estimate"; "could"; "may"; "should"; "could"; or similar statements are forward-looking statements. PharmAthene disclaims, however, any intent or obligation to update these forward-looking statements. Risks and uncertainties include, without limitation, those relating to product development, product efficacy, product demand, market acceptance, the effect of economic conditions, intellectual property rights and other risks identified in this release and in the periodic filings of the Company with the Securities and Exchange Commission. Copies of PharmAthene's public disclosure filings are available from its investor relations department.

'/>"/>

SOURCE PharmAthene, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
3. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
4. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
5. PharmAthene to Present at the BIO CEO & Investor Conference 2008
6. ScienceDirect Maximizes Research Capabilities, Enhances the Research Process
7. Thermo Fisher Scientific Executive Officers Adopting SEC Rule 10b5-1 Trading Programs
8. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
9. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
10. Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer
11. NanoSensors, Inc. Announces Reorganization of Executive Management Team and Redirection of Operations